About ArcScan
ArcScan is a company based in Golden (United States) founded in 2007. ArcScan has raised $15.21 million across 4 funding rounds from investors including Shanghai Haohai Biological Technology. The company has 18 employees as of December 31, 2022. ArcScan offers products and services including Insight 100 and EyeSeal. ArcScan operates in a competitive market with competitors including EyeNetra, EYOTO, Smart Vision Labs, PlenOptika and BroadSpot Imaging, among others.
- Headquarter Golden, United States
- Employees 18 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.21 M (USD)
in 4 rounds
-
Latest Funding Round
$11.5 M (USD), Series B
Jul 21, 2021
- Investors
-
Employee Count
18
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ArcScan
ArcScan offers a comprehensive portfolio of products and services, including Insight 100 and EyeSeal.
Robotic ultrasound for precise eye structure scanning and surgical planning.
Device for applications in pIOL sizing and glaucoma management.
People of ArcScan
Unlock access to complete
Unlock access to complete
Funding Insights of ArcScan
ArcScan has successfully raised a total of $15.21M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $11.5 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ArcScan
ArcScan has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Shanghai Haohai Biological Technology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Absorbable biomedical materials for surgeries are researched, manufactured, and sold.
|
Locked | Locked | Locked |
Investor details for ArcScan
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ArcScan
Investment portfolio details for ArcScan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ArcScan
Detailed financials for ArcScan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arcscan Comparisons
Peer comparison for ArcScan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ArcScan
ArcScan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EyeNetra, EYOTO, Smart Vision Labs, PlenOptika and BroadSpot Imaging, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Refractive errors are measured using smartphone camera attachments.
|
|
| Locked | Locked | Locked |
Ophthalmic measurement solutions are developed for eye diagnosis.
|
|
| Locked | Locked | Locked |
Refractive errors are tested via smartphone attachment by healthcare professionals.
|
|
| Locked | Locked | Locked |
Developer of a medical devices for measuring refractive errors
|
|
| Locked | Locked | Locked |
Ophthalmological imaging devices for anterior as well as posterior regions
|
Detailed competitors of ArcScan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arcscan
Complete news archive for ArcScan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ArcScan
ArcScan was founded in 2007 and raised its 1st funding round 1 year after it was founded.
ArcScan is headquartered in Golden, United States. It is registered at Golden, Colorado, United States.
Andrew Levien is the current CEO of ArcScan.
ArcScan is a funded company, having raised a total of $15.21M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at ArcScan is 18.
ArcScan has developed an ultrasound-based imaging device for ophthalmologists. The device developed is called Insight 100 that incorporates a transducer to scan the eye in arc-shaped motion. Its curvature approximates the anterior ocular surface to visualize and measure the anterior chamber depth, angle-to-angle width, individual corneal layers, sulcus-to-sulcus width with micron-level precision and repeatability. The device is used for sulcus-to-sulcus width sizing for implantable contact lenses (ICLs), corneal epithelial mapping, aid in the diagnosis of glaucoma and surgical planning. They have received FDA 510(k) clearance and CE Mark for their ArcScan Insight 100 precision ultrasound device.
ArcScan offers Insight 100 and EyeSeal.
ArcScan has 1 investor. Key investors include Shanghai Haohai Biological Technology.